title: Passive lung-targeted drug delivery systems via intravenous administration.
abstract: The treatment of lung diseases including lung cancer and tuberculosis is one of the most challenging problems in clinical practice, because the conventional drug delivery systems cannot deliver drug effectively to the lung, which result in low therapeutic effect. Therefore, lung-targeted drug delivery systems (LTDDS) that can deliver drug to the lung in an effective way to increase drug concentration in lung tissue and reduce drug distribution in other organs and tissues become an ideal strategy to treat lung diseases. The LTDDS mainly include microparticles (microspheres and microencapsules), liposomes and nanoparticles via intravenous administration, and dry powder carriers and nebulized suspensions via pulmonary inhalation. As lungs possess the large absorptive surface area, the low thickness of the epithelial barrier and good blood supply, pulmonary inhalation has received great attention. Intravenous route is the commonly practiced method for administration of larger doses of drugs into the body. Numerous drugs can be delivered directly into general circulation by avoiding their first-pass metabolism and have potential to transport drugs to the lung via intravenous administration. This present article reviews the development, evaluation and application of LTDDS via intravenous administration for the treatment of lung diseases reported in the past decades.
authors: Department of Pharmaceutics, School of Pharmacy, Luzhou Medical College , Luzhou City, Sichuan Province , P.R. China.
authors: Yumeng
authors: Y
authors: Wei
authors: Ling
authors: L
authors: Zhao
mesh_terms: D061605:Administration, Intravenous; D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D008081:Liposomes / Q000737:chemistry / Q000378:metabolism; D008168:Lung / Q000378:metabolism*; D053758:Nanoparticles / Q000737:chemistry / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*
chemical_list: D008081:Liposomes; D004364:Pharmaceutical Preparations